Clinical Trials Logo

Neoplasms, Pancreas clinical trials

View clinical trials related to Neoplasms, Pancreas.

Filter by:
  • None
  • Page 1

NCT ID: NCT02074046 Completed - Neoplasms, Pancreas Clinical Trials

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Start date: February 2014
Phase: Phase 1/Phase 2
Study type: Interventional

Most studies of cancer stem cells (CSC) involve the inoculation of cells from human tumors into immunosuppressed mice, preventing an assessment on the immunologic interactions and effects of CSCs. In this study, the investigators examined the vaccination effects produced by CSC-enriched populations from histologically distinct murine tumors after their inoculation into different syngeneic immunocompetent hosts. Enriched CSCs were immunogenic and more effective as an antigen source than unselected tumor cells in inducing protective antitumor immunity.Immune sera from CSC-vaccinated hosts contained high levels of IgG which bound to CSCs, resulting in CSC lysis in the presence of complement.CTLs generated from peripheral blood mononuclear cells or splenocytes harvested from CSC-vaccinated hosts were capable of killing CSCs in vitro. Mechanistic investigations established that CSC-primed antibodies and T cells were capable of selective targeting CSCs and conferring antitumor immunity.